
NexImmune, Inc.
NEXIOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$139
P/E Ratio—
52W High$1.01
52W Low$0.0001
NexImmune, Inc.(NEXI)股票概览
关键指标与盈利、估值、营收、股息等标签页深链。
FMP · NEXI · 截至 Jun 9, 2026
关键指标
探索 NexImmune, Inc. 数据
nexi stock data · financials竞争对手与同行
nexi competitors#TickerCompanyPriceChangeMkt Cap
#1NexImmune, Inc.
$0.00+0.00%$139#2Biocept, Inc.
$0.00+0.00%$525#3Biostar Pharmaceuticals, Inc.
$0.00+0.00%$264#4Eloxx Pharmaceuticals, Inc.
$6.20-31.11%$47.0M#5HTG Molecular Diagnostics, Inc.
$0.00+0.00%$221#6MedAvail Holdings, Inc.
$0.00+0.00%$161关于 NexImmune, Inc.
NexImmune, Inc. As a clinical-stage biotechnology firm, NexImmune, Inc. is dedicated to developing potentially curative treatments for individuals battling cancer and severe immune disorders. Their approach leverages…
what is neximmune, inc. · nexi stock overview · neximmune, inc. company profile · who is neximmune, inc. ceo · nexi OTC · neximmune, inc. headquarters · neximmune, inc. business segments
关于股票概览与关键数据
NexImmune, Inc.(NEXI)是 Biotechnology 行业的 Healthcare 类公司,于 Feb 12, 2021 在 OTC 上市。截至最近交易日,NEXI 股价为 $0.00,市值约为 $139。过去12个月累计回报 —,年初至今回报 —。
常见问题
截至最近一个交易日,NexImmune, Inc.(NEXI)股价为 $0.00,在 OTC 上市,52周区间为 $0.00 – $1.01。
NEXI 最新股价NEXI quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 9, 2026本内容不构成投资建议